BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 35899481)

  • 21. Determining Gaps in Publicly Shared SARS-CoV-2 Genomic Surveillance Data by Analysis of Global Submissions.
    Ohlsen EC; Hawksworth AW; Wong K; Guagliardo SAJ; Fuller JA; Sloan ML; O'Laughlin K
    Emerg Infect Dis; 2022 Dec; 28(13):S85-S92. PubMed ID: 36502409
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Accelerating SARS-CoV-2 genomic surveillance in a routine clinical setting with nanopore sequencing.
    Buenestado-Serrano S; Herranz M; Otero-Sobrino Á; Molero-Salinas A; Rodríguez-Grande C; Sanz-Pérez A; Durán Galván MJ; Catalán P; Alonso R; Muñoz P; Pérez-Lago L; García de Viedma D;
    Int J Med Microbiol; 2024 Mar; 314():151599. PubMed ID: 38290400
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Benchmark datasets for SARS-CoV-2 surveillance bioinformatics.
    Xiaoli L; Hagey JV; Park DJ; Gulvik CA; Young EL; Alikhan NF; Lawsin A; Hassell N; Knipe K; Oakeson KF; Retchless AC; Shakya M; Lo CC; Chain P; Page AJ; Metcalf BJ; Su M; Rowell J; Vidyaprakash E; Paden CR; Huang AD; Roellig D; Patel K; Winglee K; Weigand MR; Katz LS
    PeerJ; 2022; 10():e13821. PubMed ID: 36093336
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of Genomic Variants of SARS-CoV-2 Using Nanopore Sequencing.
    Capraru ID; Romanescu M; Anghel FM; Oancea C; Marian C; Sirbu IO; Chis AR; Ciordas PD
    Medicina (Kaunas); 2022 Dec; 58(12):. PubMed ID: 36557043
    [No Abstract]   [Full Text] [Related]  

  • 25. Genome Profiling of SARS-CoV-2 in Indonesia, ASEAN and the Neighbouring East Asian Countries: Features, Challenges and Achievements.
    Cahyani I; Putro EW; Ridwanuloh AM; Wibowo S; Hariyatun H; Syahputra G; Akbariani G; Utomo AR; Ilyas M; Loose M; Kusharyoto W; Susanti S
    Viruses; 2022 Apr; 14(4):. PubMed ID: 35458508
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advancing genomic epidemiology by addressing the bioinformatics bottleneck: Challenges, design principles, and a Swiss example.
    Chen C; Nadeau S; Topolsky I; Beerenwinkel N; Stadler T
    Epidemics; 2022 Jun; 39():100576. PubMed ID: 35605437
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early Adoption of Longitudinal Surveillance for SARS-CoV-2 among Staff in Long-Term Care Facilities: Prevalence, Virologic and Sequence Analysis.
    Gallichotte EN; Quicke KM; Sexton NR; Fitzmeyer E; Young MC; Janich AJ; Dobos K; Pabilonia KL; Gahm G; Carlton EJ; Ebel GD; Ehrhart N
    Microbiol Spectr; 2021 Dec; 9(3):e0100321. PubMed ID: 34756092
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathogen genomics in public health laboratories: successes, challenges, and lessons learned from California's SARS-CoV-2 Whole-Genome Sequencing Initiative, California COVIDNet.
    Smith EA; Libuit KG; Kapsak CJ; Scribner MR; Wright SM; Bell J; Morales C; Crumpler M; Messenger S; Hacker JK; Ledin K; Glaser C; Jacobson K; Sevinsky JR; Wadford DA
    Microb Genom; 2023 Jun; 9(6):. PubMed ID: 37267020
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SARS-CoV-2 Surveillance in the Middle East and North Africa: Longitudinal Trend Analysis.
    Post L; Marogi E; Moss CB; Murphy RL; Ison MG; Achenbach CJ; Resnick D; Singh L; White J; Boctor MJ; Welch SB; Oehmke JF
    J Med Internet Res; 2021 Jan; 23(1):e25830. PubMed ID: 33302252
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sequencing of SARS-CoV-2 in local transmission cases through Oxford Nanopore MinION platform from Karachi Pakistan.
    Mukry SN; Ahmed S; Raza Bukhari A; Shahni A; Sufaida G; Naz A; Shamsi TS
    J Infect Dev Ctries; 2021 Oct; 15(10):1376-1383. PubMed ID: 34780358
    [TBL] [Abstract][Full Text] [Related]  

  • 31. EDGE COVID-19: a web platform to generate submission-ready genomes from SARS-CoV-2 sequencing efforts.
    Lo CC; Shakya M; Connor R; Davenport K; Flynn M; Gutiérrez AMY; Hu B; Li PE; Jackson EP; Xu Y; Chain PSG
    Bioinformatics; 2022 May; 38(10):2700-2704. PubMed ID: 35561186
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CLIMB-COVID: continuous integration supporting decentralised sequencing for SARS-CoV-2 genomic surveillance.
    Nicholls SM; Poplawski R; Bull MJ; Underwood A; Chapman M; Abu-Dahab K; Taylor B; Colquhoun RM; Rowe WPM; Jackson B; Hill V; O'Toole Á; Rey S; Southgate J; Amato R; Livett R; Gonçalves S; Harrison EM; Peacock SJ; Aanensen DM; Rambaut A; Connor TR; Loman NJ;
    Genome Biol; 2021 Jul; 22(1):196. PubMed ID: 34210356
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of two-pool multiplex long-amplicon nanopore sequencing of SARS-CoV-2.
    Liu H; Li J; Lin Y; Bo X; Song H; Li K; Li P; Ni M
    J Med Virol; 2022 Jan; 94(1):327-334. PubMed ID: 34524690
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Benchmarking and Assessment of Eight
    Gupta AK; Kumar M
    OMICS; 2022 Jul; 26(7):372-381. PubMed ID: 35759429
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [ORGANIZATION OF GENOMIC SURVEILLANCE FOR SARS-CoV-2 WITHIN THE MOSCOW CITY HEALTH DEPARTMENT].
    Latypova MF; Tsibin AN; Komarov AG; Romanova VA; Speshilov GI; Tarnovetsky IY
    Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med; 2022 Dec; 30(s1):1061-1066. PubMed ID: 36385075
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Challenges of SARS-CoV-2 genomic surveillance in India during low positivity rate scenario.
    Tomar SS; Khairnar K
    Front Public Health; 2023; 11():1117602. PubMed ID: 37441634
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of genomics in combating COVID-19 pandemic.
    Saravanan KA; Panigrahi M; Kumar H; Rajawat D; Nayak SS; Bhushan B; Dutt T
    Gene; 2022 May; 823():146387. PubMed ID: 35248659
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of cobas PCR Media freezing on SARS-CoV-2 viral RNA integrity and whole genome sequencing analyses.
    Benoit P; Point F; Gagnon S; Kaufmann DE; Tremblay C; Harrigan RP; Hardy I; Coutlée F; Lapierre SG
    Diagn Microbiol Infect Dis; 2021 Dec; 101(4):115521. PubMed ID: 34537474
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genomic Surveillance for Monitoring Variants of Concern: SARS-CoV-2 Delta, Omicron, and Beyond.
    Guest PC
    Methods Mol Biol; 2022; 2511():407-413. PubMed ID: 35838978
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Challenges and Opportunities for Global Genomic Surveillance Strategies in the COVID-19 Era.
    Ling-Hu T; Rios-Guzman E; Lorenzo-Redondo R; Ozer EA; Hultquist JF
    Viruses; 2022 Nov; 14(11):. PubMed ID: 36423141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.